Impact of Adjuvant Gemcitabine Plus S-1 Chemotherapy After Surgical Resection for Adenocarcinoma of the Body or Tail of the Pancreas

Abstract

Few patients with pancreatic body or tail carcinoma are candidates for surgical resection, and the efficacy of postoperative adjuvant chemotherapy for patients with pancreatic body or tail carcinoma has not been elucidated. The aim of this study was to determine the effect of adjuvant gemcitabine and S-1 therapy for patients with adenocarcinoma of the body… (More)
DOI: 10.1007/s11605-008-0650-4

Topics

6 Figures and Tables

Cite this paper

@article{Murakami2008ImpactOA, title={Impact of Adjuvant Gemcitabine Plus S-1 Chemotherapy After Surgical Resection for Adenocarcinoma of the Body or Tail of the Pancreas}, author={Yoshiaki Murakami and Kenichiro Uemura and Takeshi Sudo and Yasuo Hayashidani and Yasushi Hashimoto and Hiroki Ohge and Taijiro Sueda}, journal={Journal of Gastrointestinal Surgery}, year={2008}, volume={13}, pages={85-92} }